Tarsus receives $15M milestone after China approves TP-03 eye treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. INTC
2. SPCX
3. DSX
4. GNK
5. AWK
6. MDA
7. ACN
8. NTMFF
9. III
10. SAN

Go back to Tarsus receives $15M milestone after China approves TP-03 eye treatment
(NASDAQ: TARS) Delayed: 63.16 --0 (-0%)
Previous Close $63.16    52 Week High $ 
Open $63.16    52 Week Low $ 
Day High $63.16    P/E N/A 
Day Low $63.16    EPS $ 
Volume 217